Rwanda: Rwanda Recalls Kenyan-Made Antibiotic Over Quality
[East African] Rwanda has recalled two batches of the Azithromycin antibiotic imported from Kenya following multiple complaints from users. (Source: AllAfrica News: Health and Medicine)
Source: AllAfrica News: Health and Medicine - February 21, 2020 Category: African Health Source Type: news

Common Antibiotics Linked To Increased Risk Of Birth Defects, Study Says
(CNN) — Taking some common antibiotics during the first trimester of pregnancy was linked with higher risk of birth defects, according to a new study. The study, published Wednesday in the medical journal BMJ, found an increased risk of birth defects in the children of women who were prescribed macrolides during the first three months of pregnancy compared to mothers who were prescribed penicillin. Macrolide antibiotics include erythromycin, clarithromycin and azithromycin, and they are used to treat infections, such as pneumonia, bronchitis and urinary, skin and sexually transmitted diseases. They are often prescrib...
Source: WBZ-TV - Breaking News, Weather and Sports for Boston, Worcester and New Hampshire - February 20, 2020 Category: Consumer Health News Authors: Health – CBS Boston Tags: Health News CNN Source Type: news

Macrolide Antibiotics Early in Pregnancy Tied to Birth Defects
Taking antibiotics like erythromycin, clarithromycin or azithromycin early in the course of pregnancy may increase the risk of birth defects. (Source: NYT Health)
Source: NYT Health - February 20, 2020 Category: Consumer Health News Authors: Nicholas Bakalar Tags: Antibiotics Pregnancy and Childbirth Birth Defects Heart Infections Source Type: news

Coronavirus: Niti CEO to find ways to reduce drug import dependence on China
The list has been compiled by the drug regulatory authority and contains antibiotics like azithromycin, amoxicillin, ofloxacin, metronidazole, vitamins such as B12, B1, B6 and E, female hormone progesterone and anticardiac arrest drug atorvastatin, among others. (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - February 20, 2020 Category: Pharmaceuticals Source Type: news

Assessing azithromycin for reducing child mortality in Africa
(Source: PharmacoEconomics and Outcomes News)
Source: PharmacoEconomics and Outcomes News - January 1, 2020 Category: Drugs & Pharmacology Source Type: news

GlaxoSmithKline announces start of phase III trial of gepotidacin in treatment of uncomplicated urinary tract infection (UTI) and urogenital gonorrhoea
Gepotidacin is first in new chemical class of antibiotics called triazaacenaphthylene bacterial topoisomerase inhibitors. Development programme comprises two separate studies, EAGLE-1 (vs. ceftriaxone + azithromycin in gonorrhoea) and EAGLE-2 (vs. nitrofurantoin for UTI). (Source: Current Awareness Service for Health (CASH))
Source: Current Awareness Service for Health (CASH) - October 30, 2019 Category: Consumer Health News Source Type: news

Long-term Antibiotics Ease Symptoms of Genetic Lung Disorder Long-term Antibiotics Ease Symptoms of Genetic Lung Disorder
Azithromycin improves symptoms for patients with primary ciliary dyskinesia, but researchers caution that vigilance must be maintained to prevent antibiotic resistance.Medscape Medical News (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - October 4, 2019 Category: Consumer Health News Tags: Pulmonary Medicine News Source Type: news

Multidrug-Resistant Salmonella Newport Outbreak Linked to U.S. Beef, Mexican Soft Cheese Multidrug-Resistant Salmonella Newport Outbreak Linked to U.S. Beef, Mexican Soft Cheese
A recent multistate outbreak of infections with multidrug-resistant Salmonella enterica serotype Newport with decreased susceptibility to azithromycin was linked to U.S. beef and Mexican cheese, according to an epidemiologic investigation.Reuters Health Information (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - September 9, 2019 Category: Consumer Health News Tags: Public Health & Prevention News Source Type: news

Outbreak of Multi-drug Resistant Salmonella Newport Outbreak of Multi-drug Resistant Salmonella Newport
An 2018 outbreak of multidrug resistant Salmonella enterica serotype Newport, with decreased susceptibility to azithromycin, has been linked to beef and raw cheese, most of which originated in Mexico.Morbidity & Mortality Weekly Report (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - September 9, 2019 Category: Consumer Health News Tags: Public Health & Prevention Journal Article Source Type: news

Outbreak of Salmonella Newport Infections with Decreased Susceptibility to Azithromycin Linked to Beef Obtained in the United States and Soft Cheese Obtained in Mexico --- United States, 2018-2019
This report summarizes an investigation of a multistate multidrug resistant Salmonella outbreak in Mexico and the United States. (Source: CDC Morbidity and Mortality Weekly Report)
Source: CDC Morbidity and Mortality Weekly Report - August 22, 2019 Category: American Health Tags: Antibiotic Use, Appropriate MMWR Morbidity & Mortality Weekly Report Salmonella Source Type: news

Trial in Africa Probes Antibiotic's Effects on Child Mortality
In Niger, fewer kids die when health workers administer azithromycin routinely, perhaps because of a shift in the composition of gut microbes. (Source: The Scientist)
Source: The Scientist - August 14, 2019 Category: Science Tags: News & Opinion Source Type: news

Amoxicillin (Moxatag) vs. Azithromycin (Zithromax)
Title: Amoxicillin (Moxatag) vs. Azithromycin (Zithromax)Category: MedicationsCreated: 8/7/2019 12:00:00 AMLast Editorial Review: 8/7/2019 12:00:00 AM (Source: MedicineNet Medications General)
Source: MedicineNet Medications General - August 7, 2019 Category: Drugs & Pharmacology Source Type: news

Medical News Today: What to know about azithromycin
Azithromycin is an antibiotic drug. It can help treat a range of bacterial infections that affect the lungs, sinuses, skin, and other parts of the body. Learn about its uses, risks, side effects, and how to use it here. (Source: Health News from Medical News Today)
Source: Health News from Medical News Today - July 12, 2019 Category: Consumer Health News Tags: Pharmacy / Pharmacist Source Type: news

Suprax (cefixime) vs. azithromycin
Title: Suprax (cefixime) vs. azithromycinCategory: MedicationsCreated: 7/9/2019 12:00:00 AMLast Editorial Review: 7/9/2019 12:00:00 AM (Source: MedicineNet Medications General)
Source: MedicineNet Medications General - July 9, 2019 Category: Drugs & Pharmacology Source Type: news

FDA Drug Safety Communication: Azithromycin (Zithromax or Zmax) and the risk of potentially fatal heart rhythms
The U.S. Food and Drug Administration (FDA) is warning the public that azithromycin (Zithromax or Zmax) can cause abnormal changes in the electrical activity of the heart that may lead to a potentially fatal irregular heart rhythm. Patients at particular risk for developing this condition include those with known risk factors such as existing QT interval prolongation, low blood levels of potassium or magnesium, a slower than normal heart rate, or use of certain drugs used to treat abnormal heart rhythms, or arrhythmias. (Source: FDA Center for Drug Evaluation and Research - What's New)
Source: FDA Center for Drug Evaluation and Research - What's New - June 22, 2019 Category: Drugs & Pharmacology Authors: FDA Source Type: news

What Causes Facial Nerve Palsy?
Discussion Facial nerve palsy has been known for centuries, but in 1821 unilateral facial nerve paralysis was described by Sir Charles Bell. Bell’s palsy (BP) is a unilateral, acute facial paralysis that is clinically diagnosed after other etiologies have been excluded by appropriate history, physical examination and/or laboratory testing or imaging. Symptoms include abnormal movement of facial nerve. It can be associated with changes in facial sensation, hearing, taste or excessive tearing. The right and left sides are equally affected but bilateral BP is rare (0.3%). Paralysis can be complete or incomplete at prese...
Source: PediatricEducation.org - June 3, 2019 Category: Pediatrics Authors: pediatriceducationmin Tags: Uncategorized Source Type: news

Medical News Today: What happens when you mix azithromycin and alcohol?
Azithromycin is a drug that has uses in treating bacterial infections. Mixing with alcohol may cause issues including nausea, headache, and dizziness or other problems. Learn more here. (Source: Health News from Medical News Today)
Source: Health News from Medical News Today - May 28, 2019 Category: Consumer Health News Tags: Alcohol / Addiction / Illegal Drugs Source Type: news

UIC to lead national COPD clinical trial
(University of Illinois at Chicago) The University of Illinois at Chicago will lead a $14.6 million, multi-center research project to determine which of two drugs -- azithromycin, an antibiotic, or roflumilast, an anti-inflammatory medication -- is the most effective at treating chronic obstructive pulmonary disease, which is also known as COPD. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - May 9, 2019 Category: International Medicine & Public Health Source Type: news

Doxycycline vs. Azithromycin
Title: Doxycycline vs. AzithromycinCategory: MedicationsCreated: 5/7/2019 12:00:00 AMLast Editorial Review: 5/7/2019 12:00:00 AM (Source: MedicineNet Medications General)
Source: MedicineNet Medications General - May 7, 2019 Category: Drugs & Pharmacology Source Type: news

New drug combination could be effective for treatment-resistant gonorrhoea
Gentamicin with azithromycin was found to be almost as effective as the currently used first-line treatment for gonorrhoea Related items fromOnMedica Promise to end new HIV transmissions in England by 2030 Use condoms to cut spread of drug-resistant gonorrhoea HPV programme linked to dramatic fall in cervical disease Uptake of PrEP coincides with less condom use Gonorrhoea becoming difficult or impossible to treat, warns WHO (Source: OnMedica Latest News)
Source: OnMedica Latest News - May 7, 2019 Category: UK Health Source Type: news

Azithromycin May Reduce Treatment Failure for COPD Exacerbations Azithromycin May Reduce Treatment Failure for COPD Exacerbations
An extended course of low-dose azithromycin may significantly reduce treatment failure in patients hospitalized for acute exacerbation of chronic obstructive pulmonary disease (COPD), new data suggest.Medscape Medical News (Source: Medscape Allergy Headlines)
Source: Medscape Allergy Headlines - May 6, 2019 Category: Allergy & Immunology Tags: Pulmonary Medicine News Source Type: news

Azithromycin May Reduce Treatment Failure for COPD
Exacerbations (Source: eMedicineHealth.com)
Source: eMedicineHealth.com - May 6, 2019 Category: General Medicine Source Type: news

Impact of Azithromycin Studied in Acute Exacerbation of COPD
Azithromycin leads to significant drops in treatment intensification and step - up in hospital care (Source: Pulmonary Medicine News - Doctors Lounge)
Source: Pulmonary Medicine News - Doctors Lounge - May 3, 2019 Category: Respiratory Medicine Tags: Internal Medicine, Critical Care, Pharmacy, Pulmonology, Journal, Source Type: news

Impact of Azithromycin Studied in Acute Exacerbation of COPD
FRIDAY, May 3, 2019 -- Three months of azithromycin did not significantly reduce treatment failure (TF) among patients hospitalized for an acute exacerbation of chronic obstructive pulmonary disease (AECOPD), according to a study published online... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - May 3, 2019 Category: Pharmaceuticals Source Type: news

Azithromycin appears to reduce treatment failure in severe, acute COPD exacerbations
(American Thoracic Society) The antibiotic azithromycin may reduce treatment failure in patients hospitalized for an acute exacerbation of chronic obstructive pulmonary disease (COPD), according to a randomized, controlled trial published online in the American Thoracic Society's American Journal of Respiratory and Critical Care Medicine. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - May 3, 2019 Category: International Medicine & Public Health Source Type: news

Drug combination could be effective for treatment-resistant gonorrhea
(National Institute for Health Research) Scientists comparing treatments for gonorrhea have identified a drug combination that could be an effective back-up for patients not responding to current therapy. The research team, from University Hospitals Birmingham, found that a treatment of the antibiotic gentamicin with azithromycin worked almost as well as the currently used ceftriaxone for genital gonorrhea. (Source: EurekAlert! - Infectious and Emerging Diseases)
Source: EurekAlert! - Infectious and Emerging Diseases - May 2, 2019 Category: Infectious Diseases Source Type: news

Gonorrhoea: Drug resistance compromises recommended treatment in Europe
(European Centre for Disease Prevention and Control (ECDC)) Gonorrhoea is the second most commonly notified sexually transmitted infection across the EU/EEA countries with almost 500 000 reported cases between 2007 and 2016. The infection is treatable but Neisseria gonorrhoeae keep showing high levels of azithromycin resistance according to latest results of the European Gonococcal Antimicrobial Surveillance Programme. This antibiotic agent is part of the currently recommended therapy regimen for gonorrhoea and observed resistance patterns threaten its effectiveness. (Source: EurekAlert! - Infectious and Emerging Diseases)
Source: EurekAlert! - Infectious and Emerging Diseases - February 28, 2019 Category: Infectious Diseases Source Type: news

Antibiotics for treating urogenital Chlamydia trachomatis infection in men and nonpregnant women
This review of 14 RCTs (n=2715) concludes in men, regimens with azithromycin are less effective than doxycycline for microbiological failure, but no difference for clinical failure; in women, it is uncertain whether azithromycin vs doxycycline increases risk of microbiological failure (Source: Current Awareness Service for Health (CASH))
Source: Current Awareness Service for Health (CASH) - February 27, 2019 Category: Consumer Health News Source Type: news

Azasite (Azithromycin Ophthalmic Solution) - updated on RxList
(Source: RxList - New and Updated Drug Monographs)
Source: RxList - New and Updated Drug Monographs - February 25, 2019 Category: Drugs & Pharmacology Source Type: news

Several antibiotics appear effective against early-stage Lyme disease
This meta-analysis suggests that when symptoms of the disease are confined to a localised skin infection, treatment failures are relatively infrequent, only 2% at 12 months. Effective antibiotics include penicillin V, doxycycline, azithromycin, cefuroxime, amoxicillin and ceftriaxone plus doxycycline.The research has significant limitations, but choice, dose and duration of antibiotics appear to have little impact on outcomes. This research does not suggest that guidelines need to be reviewed. (Source: Current Awareness Service for Health (CASH))
Source: Current Awareness Service for Health (CASH) - February 15, 2019 Category: Consumer Health News Source Type: news

Malaria Tx Plus Azithromycin Fails to Cut Deaths, Hospital Time (CME/CE)
(MedPage Today) -- African kids taking azithromycin had less frequent rates of GI infections and more (Source: MedPage Today Public Health)
Source: MedPage Today Public Health - February 4, 2019 Category: American Health Source Type: news

Azithromycin Add-On Fails to Cut Malaria Deaths, Hospital Stays
(MedPage Today) -- But less frequent infections seen in African kids who received the antibiotic (Source: MedPage Today Public Health)
Source: MedPage Today Public Health - January 30, 2019 Category: American Health Source Type: news

My High-risk Flu Patients Get Antibiotics, and Here ’s Why
Of course they get oseltamivir--but our author has been adding azithromycin for his high-risk patients since the 2015-16 season. He explains why. (Source: ConsultantLive)
Source: ConsultantLive - January 23, 2019 Category: Internal Medicine Authors: C. Andrew Schroeder, MD Tags: Respiratory Diseases Source Type: news

Featured Review: Adverse events in people taking macrolide antibiotics versus placebo for any indication
The review 'Adverse events in people taking macrolide antibiotics'   asked, “Will people taking a macrolide antibiotic experience more adverse events than those treated with placebo?”Macrolide antibiotics are one of many types of antibiotic. They are commonly used to treat both acute and chronic infections. The four most commonly used macrolides are azithromycin, clarithromycin, erythromycin, and roxithromycin. People taking macrolide antibiotics are at risk of experiencing adverse events such as nausea, diarrhoea or rashes.Lead author of the review Malene Plejdrup Hansen explains, “This review was u...
Source: Cochrane News and Events - December 17, 2018 Category: Information Technology Authors: Katie Abbotts Source Type: news

Antibiotics could extend your life by culling older cells that can no longer divide
Salford University scientists made the discovery using azithromycin, which treats infections ranging from gonorrhoea to Lyme disease. (Source: the Mail online | Health)
Source: the Mail online | Health - November 27, 2018 Category: Consumer Health News Source Type: news

Aurobindo Pharma gets USFDA nod for infections treatment drug
The company has received final approval from the US Food and Drug Administration (USFDA) to manufacture and market Azithromycin Oral suspension 100 mg /5 mL and 200 mg/5 mL. (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - October 11, 2018 Category: Pharmaceuticals Source Type: news

Azithromycin (Azasite) Ophthalmic Solution 1% (Updated - Currently in Shortage)
Drug Shortage (Source: FDA Drug Shortages)
Source: FDA Drug Shortages - October 4, 2018 Category: Drugs & Pharmacology Source Type: news

Amoxicillin-Clavulanate Remains Top Choice for Bronchiectasis Exacerbations in Kids Amoxicillin-Clavulanate Remains Top Choice for Bronchiectasis Exacerbations in Kids
Although azithromycin is noninferior to amoxicillin-clavulanate for resolving bronchiectasis exacerbations in children, the shorter time to resolution with amoxicillin-clavulanate makes it the better choice for first-line empirical antibiotic treatment, according to results from the BEST-2 trial.Reuters Health Information (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - September 28, 2018 Category: Consumer Health News Tags: Medscape Today News Source Type: news

Subbing Azithromycin for Augmentin Flops in Pediatric Bronchiectasis
(MedPage Today) -- But macrolide is option for penicillin-hypersensitive kids (Source: MedPage Today Infectious Disease)
Source: MedPage Today Infectious Disease - September 19, 2018 Category: Infectious Diseases Source Type: news

Drug-resistance of gonorrhea in the EU: persistent but stable
(European Centre for Disease Prevention and Control (ECDC)) Neisseria gonorrhoea continues to show high levels of resistance to azithromycin across the European Union and European Economic Area, according to the 2016 results of the European Gonococcal Antimicrobial Surveillance Programme (Euro-GASP). This threatens the effectiveness of the currently recommended dual therapy regimen for gonorrhea. Overall, the rates of resistance to cefixime, ceftriaxone and azithromycin have remained stable when compared to recent years. (Source: EurekAlert! - Infectious and Emerging Diseases)
Source: EurekAlert! - Infectious and Emerging Diseases - August 30, 2018 Category: Infectious Diseases Source Type: news

Zimbabwe:Drug Resistant Typhoid Is Real
[The Herald] This strain of typhoid is not responding to traditionally used medicines such as ciprofloxacin and health workers have resorted to using the last line of antibiotics, azithromycin in defence against typhoid while waiting for approvals to embark on mass vaccinations. (Source: AllAfrica News: Health and Medicine)
Source: AllAfrica News: Health and Medicine - August 21, 2018 Category: African Health Source Type: news

FDA Warns Against Long - Term Azithromycin Use for Some
Warning for blood cancer patients who have undergone donor stem cell transplant (Source: The Doctors Lounge - Oncology)
Source: The Doctors Lounge - Oncology - August 13, 2018 Category: Cancer & Oncology Tags: Infections, Oncology, Pharmacy, Pulmonology, Journal, Source Type: news

FDA Warns Against Long-Term Azithromycin Use for Some
MONDAY, Aug. 13, 2018 -- The U.S. Food and Drug Administration is warning patients with cancers of the blood or lymph nodes who undergo a donor stem cell transplant not to take azithromycin, as long-term use of the antibiotic has been associated... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - August 13, 2018 Category: Pharmaceuticals Source Type: news

La FDA advierte acerca del incremento del riesgo de reincidencia del c á ncer con el uso del antibi ó tico azitromicina (Zithromax, Zmax) a largo plazo posterior a un trasplante de c é lulas madre de donante
(Source: FDA Center for Drug Evaluation and Research - What's New)
Source: FDA Center for Drug Evaluation and Research - What's New - August 8, 2018 Category: Drugs & Pharmacology Source Type: news

La FDA advierte acerca del incremento del riesgo de reincidencia del c áncer con el uso del antibiótico azitromicina (Zithromax, Zmax) a largo plazo posterior a un trasplante de células madre de donante
(Source: FDA Center for Drug Evaluation and Research - What's New)
Source: FDA Center for Drug Evaluation and Research - What's New - August 8, 2018 Category: Drugs & Pharmacology Source Type: news

FDA Warns Against Long-Term Zmax Use in Certain Cancer Patients
(MedPage Today) -- Heightened risk of relapse, death seen in study of stem cell transplant recipients (Source: MedPage Today Public Health)
Source: MedPage Today Public Health - August 3, 2018 Category: American Health Source Type: news

FDA: Don't Use Azithromycin for Lung Condition in Cancer Patients FDA: Don't Use Azithromycin for Lung Condition in Cancer Patients
The FDA warns of an increased risk for relapse of hematologic malignancy and for death when azithromycin is used to prevent bronchiolitis obliterans syndrome in hematopoietic stem cell transplant patients.News Alerts (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - August 3, 2018 Category: Consumer Health News Tags: Hematology-Oncology News Alert Source Type: news

FDA warns about increased risk of cancer relapse with long-term use of azithromycin (Zithromax, Zmax) antibiotic after donor stem cell transplant
(Source: FDA Center for Drug Evaluation and Research - What's New)
Source: FDA Center for Drug Evaluation and Research - What's New - August 3, 2018 Category: Drugs & Pharmacology Source Type: news